Ocular Therapeutix Inc (OCUL)

Overview News Price History Option Chain Financials Why OCUL Down? Discussions Forecast

Ocular Therapeutix Inc Stock (OCUL) Financials Data

*All numbers in millions

Period End Date	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	0.18% 14.77	14.80	15.08	15.19	13.37
Cost Of Revenue	4.33% 1.326	1.386	1.377	1.304	1.214
Gross Profit	0.25% 13.45	13.41	13.70	13.88	12.16
Operating Expenses	34.66% 45.06	33.47	32.92	34.45	34.71
Interest Income/Expense	2.41% 4.051	4.151	3.426	1.991	1.768
Benefits Costs and Expenses	80.87% 79.62	44.02	34.30	35.76	43.69
Costs And Expenses	33.11% 46.39	34.85	34.30	35.76	35.92
Operating Income/Loss	57.69% -31.62	-20.05	-19.21	-20.57	-22.55
Nonoperating Income/Loss	262.39% -33.23	-9.17	18.70	-0.112	-7.769
Income/Loss From Continuing Operations Before Tax	121.93% -64.85	-29.22	-19.21	-20.68	-30.32
Income/Loss From Continuing Operations After Tax	121.93% -64.85	-29.22	-0.516	-20.68	-30.32
Net Income/Loss	121.93% -64.85	-29.22	-0.516	-20.68	-30.32
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	8,412% 132.02	1.551	79.37	78.05	77.39
Diluted Average Shares	8,412% 132.02	1.551	85.14	78.05	77.39
Basic Earnings Per Share	40.00% -0.49	-0.35	-0.01	-0.26	-0.39
Diluted Earnings Per Share	96.00% -0.49	-0.25	-0.25	-0.26	-0.39
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

GMAB

$21.50

1.61%

INCY

$74.59

1.14%

UTHR

$370.49

2.02%

MRNA

$43.06

0.76%

BGNE

$215.00

4.29%

BNTX

$118.39

1.93%